Adobe might face competition from GenAI applications. Read why investors should look beyond the hurdles this software giant ...

Neurogene received FDA Breakthrough Therapy Designation for NGN-401 in Rett Syndrome, driving a >25% share price surge. Click ...

In a letter dated February 23 to the Department of Telecom (DoT) secretary Amit Agrawal, BIF highlighted the legal opinion ...

Broadband India Forum, an industry body that represents major tech firms like Meta, Google, and others, has questioned the legal validity of the government's SIM binding mandate, citing a senior ...

An analysis of a «trampled» (blocked or stagnant) peace process requires detailed consideration. After all, when the ...

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

Half-yearly results for the six months ended 30 November 2025 PR Newswire LONDON, United Kingdom, February 27 27 ...

Introduction Burnout among healthcare professionals remains a critical public health issue linked to impaired cognition, emotional exhaustion and diminished clinical performance. Structured breathing ...

Calumet, Inc. (the "Company," "Calumet," "we," "our" or "us")  today reported its results for the fourth quarter and year ended December 31, 2025, as follows: Three Months Ended December 31, Year ...

Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness ...